Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Recent research from Gartner found that two-thirds of marketing leaders reported moderate to significant challenges demonstrating the impact of marketing campaigns on business outcomes to key ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 13 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.

Circles Around the Sun hits The Shrine this Monday night, delivering the kind of live instrumental experience that transforms passive listeners into active participants. Originally formed by the late ...

Stanley Clarke (June 30, 1951) is an American jazz musician and composer known for his innovative and influential work on double bass and electric bass as well as for his numerous film and television ...

Pivya has been proven safe in three studies. Credit: Summit Art Creations/Shutterstock. Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya ...

Alembic Pharmaceuticals Inc., the US subsidiary of Alembic Pharmaceuticals, has acquired Utility Therapeutics Ltd in a $12 million deal to strengthen its presence in the US market. Alembic will begin ...

Shares of Alembic Pharmaceuticals soared more than 12 percent in intra-day trade on Monday, June 30, after the company announced that it had secured final approval from the US Food and Drug ...

CHENNAI: Shares of Vadodara-based drug maker Alembic Pharmaceuticals jumped over 12% after the company received approval from the US Food and Drug Administration (USFDA) for its generic version of ...